| Stage | BRK-B | % of rev | SLDE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102B | 100.00% | $337M | 100.00% | BRK-B ×302.55 |
| Gross profit | $55.9B | 54.87% | $337M | 100.00% | SLDE +45.1pp |
| Operating income | $17.1B | 16.77% | $137M | 40.77% | SLDE +24.0pp |
| Pre-tax income | $31.8B | 31.25% | $162M | 48.07% | SLDE +16.8pp |
| Net income | $25.8B | 25.31% | $138M | 41.08% | SLDE +15.8pp |
| Stage | BRK-B | SLDE | Gap · A − B |
|---|---|---|---|
| Revenue | $102B100.00% | $337M100.00% | BRK-B ×302.55 |
| Gross profit | 54.87%$55.9B | 100.00%$337M | SLDE +45.1pp |
| Operating income | 16.77%$17.1B | 40.77%$137M | SLDE +24.0pp |
| Pre-tax income | 31.25%$31.8B | 48.07%$162M | SLDE +16.8pp |
| Net income |
| 25.31%$25.8B |
| 41.08%$138M |
| SLDE +15.8pp |
None
No disclosed counterparties: BRK-B.